Meenakshi Dhanawat – författare

The Microbiome and Cancer Treatment: Overcoming Resistance and Enhancing Efficacy delves into the intricate relationship between the microbiome and cancer treatment, highlighting the microbiome's critical role in drug resistance and therapeutic efficacy. The book's chapters are meticulously organized to provide a deep understanding of how the microbiome interacts with the immune system and influences cancer development and response to therapies. This book opens new avenues for investigation by providing a better understanding of the mechanisms of resistance and the role of microbiome alterations in chemoresistance.Sections also address the complex "chicken-or-egg" relationship between microbiome alterations and chemoresistance. A diverse blend of chapters foster interdisciplinary collaboration across fields such as immunology, microbiology, oncology, and pharmacology, promoting holistic approaches to cancer treatment. Readers will benefit by gaining awareness and a better understanding of how the microbiome impacts health, particularly in the context of cancer, leading to more informed health choices.Fosters a comprehensive understanding of the microbiome's role in cancer treatment, encouraging collaboration among researchers and healthcare professionals to develop holistic and innovative therapeutic strategiesProvides practical insights into microbiome-based strategies to overcome chemoresistance, such as the use of probiotics and prebiotics in cancer therapyExplores how modulating the gut microbiome can enhance the efficacy of immunotherapies, offering actionable knowledge for the development of personalized and more effective cancer treatments

Nano Drug Delivery for Colon Cancer: Innovations, Challenges, and Applications is a breakthrough exploration that delves into the latest advancements in colon cancer diagnosis and treatment. This comprehensive guide, composed of 11 detailed chapters, focuses on the design, synthesis, and application of various nanodrug delivery systems, showcasing how nanoparticulate drug carriers can significantly enhance therapeutic efficacy through strategic design. Aimed at graduates, clinical researchers, and scientists, this book addresses the complexities and challenges in drug and gene delivery. Beyond its technical insights, the book highlights the global health impact of colon cancer and offers a roadmap for developing more efficient and targeted treatments.It serves as a vital resource, fostering interdisciplinary knowledge and advancements that have the potential to revolutionize colon cancer therapeutics. The book's interdisciplinary approach ensures it is a beacon of knowledge for those seeking to navigate and innovate within this critical field.Delivers an in-depth exploration of the design, synthesis, and application of nanodrug delivery systemsUnveils groundbreaking and state-of-the-art approaches in colon cancer diagnosis and treatment, placing readers at the cutting edge of medical innovationShowcases how strategic design methodologies can dramatically boost therapeutic efficacy, paving the way for more effective colon cancer treatments

Polymer Nanofiber Applications in Cancer Wound Healing: Advances, Challenges, and Future Directions explores the use of nanoscale polymeric fibers for targeted cancer therapy and wound healing. This book addresses the need for therapeutic platforms that deliver treatment directly to tumor sites, minimizing the adverse effects on healthy tissues. It covers advances in nanofiber and biopolymer membrane development for applications such as transdermal delivery, skin regeneration, and tissue engineering, while examining the challenges and potential advancements in localized cancer treatment and wound healing.Polymer Nanofiber Applications in Cancer Wound Healing: Advances, Challenges, and Future Directions is of interest to researchers and academics in the fields of materials science, materials chemistry, pharmaceutical sciences, and cancer research.Details the characteristics, properties, and processing of polymer nanofiber biomaterials for cancer wound healing and repairReviews traditional and novel treatments in cancer therapy, including topical therapeutics and personalized medicinesExplores the use of AI in nanofiber technologyAssesses clinical trials and patents for polymer nanofiber-based cancer treatments, as well as production and commercialization challenges

Diagnostic Application of Blood-based Biomarkers for Neurodegenerative Diseases is a comprehensive exploration of the pivotal role blood-based biomarkers play in diagnosing and managing neurological disorders. This comprehensive guide emphasizes the need for early detection and intervention in conditions such as Alzheimer’s disease, Parkinson’s disease, and neuroinflammation. Each chapter delves into specific biomarkers, including glial fibrillary acidic protein and neurofilaments, elucidating their diagnostic potential. This book highlights recent advancements in the application of blood biomarkers across various neurodegenerative diseases, underscoring the integration of artificial intelligence in biomarker discovery. By bridging research and clinical practice, it serves as an essential resource for professionals in diagnostic sciences, pharmaceutical research, and clinical pharmacology. Ultimately, this volume aims to reshape the landscape of early diagnosis, offering insights that promise to enhance personalized treatment strategies and improve patient outcomes in the fight against debilitating neurological disorders.Explores the latest research on emerging blood-based biomarkers specific to various neurodegenerative diseasesAnalyzes case studies showcasing successful implementations of blood biomarkers in clinical settingsHighlights the role of interdisciplinary collaboration in advancing biomarker research, emphasizing the importance of partnerships between neurology, biotechnology, and data scienceDiscusses the ethical considerations and regulatory challenges associated with the clinical use of blood-based biomarkersProposes future directions for research and clinical practice, identifying gaps in current knowledge and potential avenues for innovation in neurodegenerative disease diagnostics